Medtronic ROE 2006-2019 | MDT

Current and historical return on equity (ROE) values for Medtronic (MDT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Medtronic ROE for the three months ending October 31, 2019 was 14.52%.
Medtronic ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-10-31 $4.67B $50.72B 9.27%
2019-07-31 $4.42B $50.50B 8.82%
2019-04-30 $4.63B $50.21B 9.25%
2019-01-31 $4.92B $49.94B 9.80%
2018-10-31 $2.26B $49.71B 4.49%
2018-07-31 $3.16B $50.33B 6.23%
2018-04-30 $3.10B $50.82B 6.10%
2018-01-31 $2.81B $50.34B 5.53%
2017-10-31 $5.02B $51.58B 9.93%
2017-07-31 $4.12B $50.79B 8.19%
2017-04-30 $4.03B $50.33B 8.02%
2017-01-31 $3.97B $49.49B 7.83%
2016-10-31 $4.24B $50.29B 8.32%
2016-07-31 $3.65B $50.89B 7.08%
2016-04-30 $3.54B $52.06B 6.81%
2016-01-31 $2.43B $50.82B 4.66%
2015-10-31 $2.32B $52.27B 5.19%
2015-07-31 $2.62B $52.81B 7.21%
2015-04-30 $2.68B $53.23B 9.55%
2015-01-31 $3.12B $20.17B 15.96%
2014-10-31 $2.91B $19.44B 15.02%
2014-07-31 $2.98B $19.25B 15.54%
2014-04-30 $3.07B $19.44B 16.12%
2014-01-31 $3.59B $19.35B 19.05%
2013-10-31 $3.81B $18.74B 20.67%
2013-07-31 $3.56B $18.52B 19.70%
2013-04-30 $3.47B $18.67B 19.55%
2013-01-31 $3.49B $17.84B 20.11%
2012-10-31 $3.44B $17.18B 20.00%
2012-07-31 $3.66B $17.26B 21.44%
2012-04-30 $3.62B $17.11B 21.48%
2012-01-31 $3.40B $17.17B 20.56%
2011-10-31 $3.39B $16.74B 21.07%
2011-07-31 $3.09B $16.34B 19.76%
2011-04-30 $3.10B $15.97B 20.38%
2011-01-31 $3.28B $15.36B 22.05%
2010-10-31 $3.18B $14.83B 21.80%
2010-07-31 $3.48B $14.60B 24.38%
2010-04-30 $3.10B $14.63B 22.25%
2010-01-31 $2.25B $14.32B 16.56%
2009-10-31 $2.11B $13.61B 15.95%
2009-07-31 $1.79B $13.14B 13.78%
2009-04-30 $2.07B $13.18B 16.20%
2009-01-31 $2.69B $13.06B 21.74%
2008-10-31 $2.07B $12.62B 17.46%
2008-07-31 $2.19B $12.24B 18.92%
2008-04-30 $2.14B $11.54B 18.95%
2008-01-31 $2.23B $10.97B 20.02%
2007-10-31 $2.86B $11.48B 25.69%
2007-07-31 $2.88B $11.14B 26.54%
2007-04-30 $2.80B $10.98B 26.60%
2007-01-31 $2.73B $10.98B 26.93%
2006-10-31 $2.69B $10.28B 26.05%
2006-07-31 $2.83B $9.90B 26.81%
2006-04-30 $2.55B $9.38B 23.78%
2006-01-31 $2.00B $11.74B 18.25%
2005-10-31 $1.88B $11.13B 17.71%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $152.160B $30.557B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.706B 27.85
Stryker (SYK) United States $75.917B 25.53
Boston Scientific (BSX) United States $62.848B 29.66
Baxter (BAX) United States $42.866B 25.99
Essilor Luxottica (ESLOY) France $34.245B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.456B 19.11
Terumo (TRUMY) Japan $27.092B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.394B 0.00
Coloplast (CLPBY) Denmark $24.797B 38.27
ResMed (RMD) United States $22.090B 40.75
Smith & Nephew SNATS (SNN) United Kingdom $20.228B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $10.859B 516.62
Bio-Rad Laboratories (BIO) United States $10.615B 50.95
William Demant Holdings (WILYY) Denmark $7.675B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.340B 13.69
Hill-Rom Holdings (HRC) United States $7.289B 21.49
Canopy Growth (CGC) Canada $7.208B 0.00
Haemonetics (HAE) United States $5.904B 39.89
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.947B 31.08
ICU Medical (ICUI) United States $3.686B 24.03
Neogen (NEOG) United States $3.583B 59.96
GW Pharmaceuticals (GWPH) United Kingdom $3.293B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.073B 0.00
Quidel (QDEL) United States $2.950B 27.99
Aurora Cannabis (ACB) Canada $2.865B 0.00
Agios Pharmaceuticals (AGIO) United States $2.750B 0.00
National Vision Holdings (EYE) United States $2.495B 56.30
Cardiovascular Systems (CSII) United States $1.607B 0.00
Aphria (APHA) $1.384B 0.00
InMode (INMD) Israel $1.242B 0.00
AtriCure (ATRC) United States $1.206B 0.00
VAREX IMAGING (VREX) United States $1.199B 24.01
TG Therapeutics (TGTX) United States $1.006B 0.00
Phibro Animal Health (PAHC) United States $0.969B 18.14
NanoString Technologies (NSTG) United States $0.912B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.820B 31.41
Lantheus Holdings (LNTH) United States $0.795B 19.86
LeMaitre Vascular (LMAT) United States $0.711B 39.98
PetIQ (PETQ) United States $0.695B 16.96
Quanterix (QTRX) United States $0.676B 0.00
Omeros (OMER) United States $0.667B 0.00
HEXO (HEXO) $0.576B 0.00
Cerus (CERS) United States $0.560B 0.00
Surmodics (SRDX) United States $0.552B 57.38
MacroGenics (MGNX) United States $0.518B 0.00
OraSure Technologies (OSUR) United States $0.497B 29.80
Meridian Bioscience (VIVO) United States $0.413B 14.21
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.68
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.320B 130.58
Zynex (ZYXI) United States $0.305B 34.48
Bovie Medical (APYX) United States $0.276B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.274B 0.00
United Health Products (UEEC) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Viemed Healthcare (VMD) United States $0.238B 25.08
Repro-Med Systems (KRMD) United States $0.228B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.172B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Female Health (VERU) United States $0.157B 0.00
Rockwell Medical (RMTI) United States $0.142B 0.00
Cytosorbents (CTSO) United States $0.136B 0.00
Fonar (FONR) United States $0.130B 9.18
MTech Acquisition (KERN) United States $0.128B 0.00
Chimerix (CMRX) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 22.93
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00